Takeda Pharmaceutical Limited
TAK | NYSE
$19
+$0.11 (+0.58%)
Sep 22, 2026, 12:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Mar 30, 2026 | FY 2024 Mar 30, 2025 | FY 2023 Mar 30, 2024 | FY 2022 Mar 30, 2023 | FY 2021 Mar 30, 2022 | FY 2020 Mar 30, 2021 |
|---|---|---|---|---|---|---|
Net Income | -152.13B | 108.14B | 144.2B | 317.04B | 230.17B | 376.17B |
Depreciation & Amortization | 721.13B | 761.4B | 728B | 664.4B | 583.15B | 559.67B |
Stock-Based Compensation | 72.78B | 72.87B | 70.87B | 60.67B | 43.37B | 37.66B |
Other Working Capital | 331.36B | 34.56B | -155.36B | -21.24B | 17.46B | 259.12B |
Other Non-Cash Items | 189.98B | 107.21B | 120.68B | -97.74B | 95.4B | -228.42B |
Deferred Income Tax | 9.77B | 66.94B | -91.41B | 58.05B | 72.41B | -9.94B |
Change in Working Capital | 199.91B | -59.37B | -256B | -25.26B | 98.61B | 275.78B |
Operating Cash Flow | 1.04T | 1.06T | 716.34B | 977.16B | 1.12T | 1.01T |
Capital Expenditures | -414.66B | -379.63B | -480.73B | -633.69B | -186.04B | -236.47B |
Cash Acquisitions | 33.58B | 77.24B | 19.96B | 7.96B | -21.48B | 530.39B |
Purchase of Investments | -17.43B | -111.38B | -40.07B | -10.15B | -8.34B | -12.6B |
Sales Maturities Of Investments | 7.03B | 29.44B | 8.02B | 22.25B | 16.92B | 74.6B |
Other Investing Acitivies | -216.32B | -161.57B | -276.36B | -486.51B | -61.98B | -87.66B |
Investing Cash Flow | -369.14B | -367.06B | -463.86B | -607.1B | -198.13B | 393.53B |
Debt Repayment | 1.08B | -314.31B | 1.51B | -285.07B | -600.48B | -660.5B |
Common Stock Repurchased | -51.6B | -51.86B | -2.33B | -26.93B | -77.53B | -2.14B |
Dividend Paid | -311.9B | -302.5B | -287.19B | -279.42B | -283.67B | -283.36B |
Other Financial Acitivies | -134.39B | -82.75B | -66.42B | -117.73B | -108.59B | -142.35B |
Financial Cash Flow | -496.82B | -751.43B | -354.42B | -709.15B | -1.07T | -1.09T |
Net Cash Flow | 209.94B | -72.69B | -75.73B | -316.17B | -116.53B | 328.61B |
Free Cash Flow | 626.77B | 677.56B | 235.61B | 343.47B | 937.07B | 774.46B |
Adj. Free Cash Flow | 554B | 604.69B | 164.74B | 282.8B | 893.69B | 736.8B |
Maintenance CapEx | -328.39B | -235.02B | -374.83B | -435.78B | -29.65B | -236.47B |
Growth CapEx | -86.27B | -144.61B | -105.9B | -197.91B | -156.39B | n/a |
Owner Earnings | 713.04B | 822.16B | 341.51B | 541.38B | 1.09T | 774.46B |
Add to Watchlist
Select watchlists to add or remove TAK